JNJ
Johnson & Johnson
Company Overview
| Mkt Cap | $459.32B | Price | $188.87 |
| Volume | 8.79M | Change | -0.10% |
| P/E Ratio | 32.7 | Open | $187.46 |
| Revenue | $88.8B | Prev Close | $189.05 |
| Net Income | $14.1B | 52W Range | $140.68 - $194.48 |
| Div Yield | 5.20% | Target | $201.26 |
| Overall | 56 | Value | 50 |
| Quality | -- | Technical | 63 |
No chart data available
Stock Overview
Updated DailyJohnson & Johnson (JNJ) is a leading Healthcare company in the Drug Manufacturers - Major industry, currently trading at $188.87 with a market capitalization of $459.32 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows JNJ with a volume of 8.79 million shares. The stock opened down 0.84% from yesterday's close of $189.05. Current analyst estimates project earnings of $10.86 per share for this year, with next year targeting $11.46.
JNJ demonstrates positive technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including PFE, MRK, SNY, NVS, SYK.
Key investment considerations for JNJ include average overall investment profile. The company offers a dividend yield of 5.2% and analyst price targets suggest potential upside of 6.6%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 12:23 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JNJ | $188.87 | -0.1% | 8.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |